Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Better U Care vs Mevo Health

Better U Care
Graded #234

Higher grade

vs+4.599999999999994
Mevo Health
Graded #326

Lower grade

The verdict

Better U Care takes it — 64.8/100 to 60.2/100.

Better U Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Better U Care is a US telehealth weight-loss practice offering compounded and brand-name GLP-1 medications with transparent self-pay pricing and no insurance required.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMevo Health +8
48
56
Dose & formulationBetter U Care +2
85
83
Clinical oversightBetter U Care +7
74
67
Labs & monitoringEven
52
52
FulfillmentBetter U Care +16
73
57
Contract termsBetter U Care +35
55
20
Better U Care · left barMevo Health · right bar

The numbers

MetricBetter U CareMevo Health
WeighScore64.8/10060.2/100
GradeCC
Scorecard rank#234#326
Semaglutide$298/mo$199/mo (all doses, compounded)
Tirzepatide$397/mo$259/mo (all doses, compounded)
Coverage21 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Better U Care

Graded #234 · C

Strengths

  • Transparent self-pay pricing with no insurance required
  • Offers both compounded and brand-name semaglutide and tirzepatide
  • Uniform compounded pricing across all doses with supplies included
  • Publishes its full list of covered states

Where it loses points

  • Available in 21 states rather than nationwide
  • Does not name a compounding pharmacy or list an accreditation seal
  • Brand medications carry a separate 150 dollar consult fee
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard